US EditionDr. Martens Says Its Fall Order Books Are ‘Healthy’ as New Fiscal Year Starts In-Line With Expectations
UNITED KINGDOM, JUL 10 – Dr Martens reports stable FY26 outlook despite UK challenges, driven by strong growth in Asia-Pacific and Americas with healthy global autumn/winter order books, company said.
6 Articles
6 Articles
Dr Martens maintains guidance despite ‘challenging’ UK trading
Dr Martens has reported that trading since the beginning of the financial year has remained “in line with expectations”, although its UK operations continue to face a “challenging trading backdrop”. Ahead of its AGM, the group also stated that all guidance for the 2026 financial year remains unchanged. Regionally, Dr Martens reported positive trading in its Americas direct-to-consumer (DTC) channel, particularly in retail, where full-price sales…
Dr Martens ‘on track’ despite ‘challenging’ UK trading - Retail Gazette
Dr Martens confirmed it was trading in line with management expectations, despite the continued “challenging trading backdrop” for its UK business. In an update ahead of its AGM, the shoe maker said its guidance for FY26 remains unchanged and its order books globally for the upcoming Autumn/Winter season are “healthy”. The retailer reported “positive trading” in its Americas Direct to Consumer (DTC) channel, driven by full price sales mostly in …
Dr Martens in 'global health' despite 'challenging UK trading'
Drapers Dr Martens in ‘global health’ despite ‘challenging UK trading’ Ahead of its annual general meeting today (10 July), British footwear brand and manufacturer Dr Martens has stated all full-year guidance for 2025/26 remains unchanged, despite reporting plummeting profits for 2024/25.The post Dr Martens in ‘global health’ despite ‘challenging UK trading’ appeared first on Drapers.
The UK-based shoe firm Dr. Martens aspires to grow both through the DTC channel (including online), and through wholesale. A strategy that provides a marketing path for the brand and allows it to access customers who may not know what brand they want to buy. Without going further, for Dr. Martens, fiscal year 2025 was a year of stabilization. It has also been a complex and changing year, as earlier this year Ije Nwokorie assumed the position of …
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
